Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)
Condition(s):Primary Immune ThrombocytopeniaLast Updated:July 2, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Primary Immune ThrombocytopeniaLast Updated:July 2, 2021Unknown status
Condition(s):Idiopathic Thrombocytopenic PurpuraLast Updated:March 12, 2020Unknown status
Condition(s):Primary Immune ThrombocytopeniaLast Updated:December 6, 2023Recruiting
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:October 19, 2022Not yet recruiting
Condition(s):Thrombocytopenic PurpuraLast Updated:August 9, 2017Unknown status
Condition(s):Idiopathic Thrombocytopenic PurpuraLast Updated:April 9, 2015Terminated
Condition(s):Immune ThrombocytopeniaLast Updated:October 10, 2023Not yet recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:January 3, 2020Unknown status
Condition(s):Idiopathic PurpuraLast Updated:October 25, 2021Completed
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:February 12, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.